Exhibit 967

Merck & Co., Inc. definitive proxy statement (DEF 14A), security ownership table

Exhibit 967 · Company filing

Merck & Co., Inc. definitive proxy statement (DEF 14A), security ownership table

As reported on Amendment No. 14 to Schedule 13G (the “BlackRock filing”) filed with the SEC on January 26, 2024, which is the most recently filed Schedule 13G with respect to the Company.

Lists one holder above 5%: BlackRock 201,836,434 (8.17%; Amendment No. 14 to 13G filed 26 Jan 2024 as of 31 Dec 2023, “the most recently filed Schedule 13G with respect to the Company”). Vanguard and State Street are not listed.

Source: Merck & Co., Inc.
Date: 8 April 2026
Quoted from: Beneficial ownership table, note (1)
Grade: Primary record
Document: https://www.sec.gov/Archives/edgar/data/310158/000119312526147704/d85708ddef14a.htm
Accessed: 2026-11-10
Cited by: Findings citing this exhibit

Cited by

Finding INF-1.3: Primary record Proxy statements filed from January to September 2026 list at least one of Vanguard, BlackRock and State Street as holding more than 5 percent of the common stock of each of 17 companies: eight media, five pharmaceutical and four defense. The listed stakes run from 5.1 to 14.9 percent, and 14 of the 17 proxies cite at least one Schedule 13G filed between January and April 2024, so the percentages describe holdings on dates from 31 December 2023 to 30 June 2026.